Estera Phase II

Retirée du marché américain le 16 October 2023 (selon le DSLD)

Pharmanex, food supplement from the US market

Label withdrawn from the US market. Estera Phase II (Pharmanex), a food supplement without a usable barcode in DSLD, is described by its US market label, recorded on 25 April 2018. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label, entered on 25 April 2018. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand: Pharmanex
Barcode: Not provided or invalid in DSLD
Form: Capsule
One serving: 1 capsule
Servings: up to 1 serving per day
Other ingredients (in English, as written): Gelatin, Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide

Ingredient (as written, in English)	Category	Per serving
Broccoli powder (Brassica oleracea)	Plant	150 mg
Diindolylmethane	Other substance	100 mg
Black Cohosh (Cimicifuga racemosa) extract (Actaea racemosa)	Plant	40 mg
Pomegranate fruit (Punica granatum) extract (Punica granatum)	Plant	40 mg
Lignans	Other substance	20 mg
Genistein	Other substance	15 mg

Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

Official label: Estera Phase II
Entered into DSLD on 25 November 2013. Retirée du marché américain le 19 January 2018 (selon le DSLD).
Same active composition.

Source

Official label

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List declared on 25 April 2018 (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging

Brand : Pharmanex